Bank of Montreal’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$413K Buy
7,461
+741
+11% +$35.3K ﹤0.01% 2483
2025
Q4
$251K Hold
6,720
﹤0.01% 2706
2025
Q3
$272K Buy
+6,720
New +$222K ﹤0.01% 2578
2021
Q2
Sell
-5,170
Closed -$127K 4582
2021
Q1
$127K Sell
5,170
-219
-4% -$4.95K ﹤0.01% 3294
2020
Q4
$113K Buy
5,389
+3,149
+141% +$57.9K ﹤0.01% 3520
2020
Q3
$40K Sell
2,240
-485
-18% -$10.3K ﹤0.01% 3529
2020
Q2
$67K Buy
2,725
+1,213
+80% +$30.1K ﹤0.01% 3277
2020
Q1
$37K Sell
1,512
-1,532
-50% -$37.4K ﹤0.01% 3014
2019
Q4
$76K Buy
3,044
+1,002
+49% +$23.3K ﹤0.01% 3624
2019
Q3
$43K Sell
2,042
-86,002
-98% -$2.36M ﹤0.01% 3701
2019
Q2
$2.8M Sell
88,044
-5,614
-6% -$176K ﹤0.01% 1488
2019
Q1
$3.09M Sell
93,658
-3,911
-4% -$122K ﹤0.01% 1434
2018
Q4
$3.14M Buy
97,569
+10,631
+12% +$401K ﹤0.01% 1308
2018
Q3
$3.73M Buy
86,938
+20,675
+31% +$977K ﹤0.01% 1347
2018
Q2
$3.05M Sell
66,263
-3,672
-5% -$163K ﹤0.01% 1414
2018
Q1
$2.78M Sell
69,935
-4,733
-6% -$175K ﹤0.01% 1413
2017
Q4
$2.5M Sell
74,668
-25,738
-26% -$914K ﹤0.01% 1488
2017
Q3
$3.72M Buy
100,406
+45,948
+84% +$1.73M ﹤0.01% 1295
2017
Q2
$2.02M Buy
54,458
+9,572
+21% +$312K ﹤0.01% 1619
2017
Q1
$1.26M Buy
44,886
+41,760
+1,336% +$1.18M ﹤0.01% 1764
2016
Q4
$86K Buy
3,126
+515
+20% +$14.1K ﹤0.01% 2905
2016
Q3
$71K Buy
2,611
+1,001
+62% +$22.6K ﹤0.01% 2931
2016
Q2
$30K Sell
1,610
-256,955
-99% -$5.36M ﹤0.01% 3230
2016
Q1
$6.99M Sell
258,565
-73,047
-22% -$2.09M 0.01% 897
2015
Q4
$9.99M Sell
331,612
-3,412
-1% -$109K 0.01% 723
2015
Q3
$10.6M Sell
335,024
-4,254
-1% -$155K 0.01% 684
2015
Q2
$13.2M Buy
339,278
+67,981
+25% +$2.34M 0.02% 686
2015
Q1
$9.61M Buy
271,297
+267,697
+7,436% +$8.62M 0.01% 823
2014
Q4
$114K Buy
3,600
+3,410
+1,795% +$94.3K ﹤0.01% 2711
2014
Q3
$4K Buy
+190
New +$3.81K ﹤0.01% 3829

Other funds holding PAHC

Bank of Montreal's PAHC Position: Q1 2026 in Review

Bank of Montreal increased its Phibro Animal Health (PAHC) stake by 11% in Q1 2026, buying an estimated $35.3K and bringing the position to 7,461 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #2483.

Bank of Montreal first reported a position in PAHC in Q3 2014 and has held it in 30 quarters since. The position peaked at $13.2M in Q2 2015. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Bank of Montreal held 7,461 shares of Phibro Animal Health worth $413K as of Q1 2026.
  • Bank of Montreal bought 741 Phibro Animal Health shares in Q1 2026, an estimated $35.3K.
  • Phibro Animal Health made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2483 holding.
  • Bank of Montreal first reported a position in Phibro Animal Health in Q3 2014 and has held it in 30 quarters since.
  • Bank of Montreal's Phibro Animal Health position peaked at $13.2M in Q2 2015.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.